A breakthrough inantitumor therapy occurred with the advent of the drug Herceptin (trastuzumab),which is a humanized antibody to the extracellular domain of ErbB2 [8-10],which inhibits the proliferation of tumor cells. The gene discussed is ERBB2; the disease is neoplasm.